GGPS Antibodies

Santa Cruz Biotechnology features a diverse variety of monoclonal GGPS Antibodies for investigating geranylgeranyl pyrophosphate synthase (GGPS) function and regulation. Monoclonal GGPS Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).Geranylgeranyl pyrophosphate synthase plays a crucial role in the biosynthesis of isoprenoids, which are essential for numerous cellular processes, including protein prenylation, cell signaling, and membrane integrity. The regulation of GGPS is vital for maintaining cellular homeostasis and has implications in various diseases, including cancer and cardiovascular disorders. Understanding GGPS function can provide insights into therapeutic targets and potential interventions. GGPS research has revealed significant connections between isoprenoid biosynthesis and cellular health. Recent studies have highlighted the importance of GGPS in multiple biological pathways and disease mechanisms. Investigating GGPS activity patterns helps advance knowledge about metabolic regulation and disease progression. Santa Cruz Biotechnology monoclonal GGPS Antibodies enable researchers worldwide to advance scientific understanding of cellular processes and disease mechanisms.